Bone Degeneration Therapeutics Market: By Drug Type (Hyaluronic acid, Platelet rich plasma, Steroids and cortisone, Others),By Route of Administration (Oral, Parenteral), By Application (Osteopenia, Osteoarthritis, Spinal Fusion), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies),and Geography    

Purchase Option

$ 4400
$ 4600
$ 6900

Bone Degeneration Therapeutics Market size was valued at USD 8.32 billion in 2022, growing at a CAGR of 9.2% from 2023-2029. Bone degeneration is characterized by the deterioration of articular cartilage casing the joints. Cartilage provides helps to free movement of joint without friction. Deterioration of the cartilage leads to the reduce in flexibility of joint movements and causes compressed nerve, inflammation, and pain. Bone degeneration is majorly occurs due to congenital disorders, injuries, diabetes, and obesity among others. Symptoms associated with bone degeneration include joint stiffness, numbness in case of bone spurs, pain in back, and joint inflammation. Global bone degeneration therapeutics market is segmented on the basis of drug type, rout of administration, application, distribution channel, and region.  The articular cartilage that covers the joints deteriorates with bone degeneration. Cartilage allows the joint to move freely and without resistance. Inflammation, squeezed nerves, and discomfort result from a reduction in joint flexibility caused by cartilage degeneration. Bone degradation is a normal process that is accelerated by a variety of factors such as traumas, congenital diseases, diabetes, and obesity. Joint stiffness, radiating pain that starts in the back and progresses to the limbs, and joint inflammation are all symptoms of degenerative bone problems.

The Bone Degeneration Therapeutics Market Key Developments:
  • In October 2017, Flexion Therapeutics received FDA approval for Zilretta used in the treatment of osteoarthritis knee pain.

Bone Degeneration Therapeutics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Bone Degeneration Therapeutics Market Dynamics

Drivers are increasing in the prevalence of diabetes and obesity, Drug approvals for bone degeneration therapeutics combined with patent expiries of blockbuster drugs and Strong pipeline products.Restraints are Stringent regulatory policies for product approval, High cost of treatment and Less number of existed drugs, and limited treatment options available in the market.

Key Features of the Reports

  • The Bone Degeneration Therapeutics Market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Bone Degeneration Therapeutics Market Segmentation

By Drug Type
  • Hyaluronic acid
  • Platelet rich plasma
  • Steroids and cortisone
  • Others
Route-administration
  • Oral
  • Parenteral
By Application
  • Osteopenia
  • Osteoarthritis
  • Spinal Fusion
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Bone Degeneration Therapeutics Market size was valued at USD 8.32 billion in 2022, growing at a CAGR of 9.2% from 2023-2029.

The key opportunities for the bone degeneration therapeutics market include an aging population, increasing awareness and early diagnosis, and advancements in regenerative medicine and biotechnology.

Asia Pacific is the fastest-growing for bone degeneration therapeutics market

  1. Table of Content
  2. Executive Summary
  3. Global Bone Degeneration Therapeutics Market Introduction
    • Global Bone Degeneration Therapeutics Market - Taxonomy
    • Global Bone Degeneration Therapeutics Market - Definitions
      • Drug Type
      • Route of Administration
      • Application
      • Distribution Channel
  1. Global Bone Degeneration Therapeutics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Bone Degeneration Therapeutics Market Dynamic Factors - Impact Analysis
    • Global Bone Degeneration Therapeutics Market - Competition Landscape
    • Epidemiology
  2. Global Bone Degeneration Therapeutics Market Analysis,2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Bone Degeneration Therapeutics Market, By Drug Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Hyaluronic acid
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Platelet rich plasma
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Steroids and cortisone
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Bone Degeneration Therapeutics Market Forecast, By Route of Administration,2018 - 2022 and Forecast, 2023 - 2029
    • Oral
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Bone Degeneration Therapeutics Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Osteopenia
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Osteoporosis
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Spinal fusion
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Bone Degeneration Therapeutics Market Forecast, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Bone Degeneration Therapeutics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Bone Degeneration Therapeutics Market - Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel and Region, 2023 - 2029
  2. North America Bone Degeneration Therapeutics MarketAnalysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Hyaluronic acid
      • Platelet rich plasma
      • Steroids and cortisone
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Osteopenia
      • Osteoporosis
      • Spinal fusion
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Bone Degeneration Therapeutics Market - Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel and Country, 2023 - 2029
    • North America Bone Degeneration Therapeutics Market Dynamics - Trends
  3. Europe Bone Degeneration Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Hyaluronic acid
      • Platelet rich plasma
      • Steroids and cortisone
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Osteopenia
      • Osteoporosis
      • Spinal fusion
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Bone Degeneration Therapeutics Market - Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel and Country, 2023 - 2029
    • Europe Bone Degeneration Therapeutics Market Dynamics - Trends
  4. Asia-Pacific Bone Degeneration Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Hyaluronic acid
      • Platelet rich plasma
      • Steroids and cortisone
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Osteopenia
      • Osteoporosis
      • Spinal fusion
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Bone Degeneration Therapeutics Market - Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel and Country, 2023 - 2029
    • Asia-Pacific Bone Degeneration Therapeutics Market Dynamics - Trends
  5. Latin America Bone Degeneration Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Hyaluronic acid
      • Platelet rich plasma
      • Steroids and cortisone
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Osteopenia
      • Osteoporosis
      • Spinal fusion
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Bone Degeneration Therapeutics Market - Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel and Country, 2023 - 2029
    • Latin America Bone Degeneration Therapeutics Market Dynamics - Trends
  6. Middle East and Africa Bone Degeneration Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Hyaluronic acid
      • Platelet rich plasma
      • Steroids and cortisone
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Osteopenia
      • Osteoporosis
      • Spinal fusion
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Bone Degeneration Therapeutics Market - Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel and Country, 2023 - 2029
    • MEA Bone Degeneration Therapeutics Market Dynamics - Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Fate Therapeutics (U.S.)
      • Amgen, Inc. (U.S.)
      • Regenexx (U.S.)
      • Bone Therapeutics SA (Belgium)
      • Se-cure Pharmaceuticals, Ltd. (Israel)
      • Kaken Pharmaceutical Co., Ltd. (Japan)
      • Flexion Therapeutics, Inc. (U.S.)
  8. Research Methodology
  9. Key Assumptions and Acronyms
  • Fate Therapeutics (U.S.)
  • Amgen, Inc. (U.S.)
  • Regenexx (U.S.)
  • Bone Therapeutics SA (Belgium)
  • Se-cure Pharmaceuticals, Ltd. (Israel)
  • Kaken Pharmaceutical Co., Ltd. (Japan)
  • Flexion Therapeutics, Inc. (U.S.)

Adjacent Markets